Fermer le menu


Member of Lyonbiopole


Founded in 2010, Amoéba is a cleantech specialized in the research and development of alternative solutions for the treatment of natural resources. The company develops two technologies: a biological biocide capable of eliminating bacterial risk in industrial water treatment and a biocontrol agent able to fight phytopathogenic microorganisms in agriculture. These natural solutions, based on the Willaertia magna C2c Maky amoeba, are efficient alternatives to the chemical treatments traditionally used in industry.

Amoeba is currently focusing on the industrial cooling towers market, estimated at €1.7 billion out of a global market for chemical biocides for water treatment, estimated at €21 billion and on the fungicides, market estimated at €12 billion. AMOEBA is quoted on the Euronext Growth stock exchange.


Strategic application domain: Medical Technologies

Application market: Others

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Others

Created on july 21st, 2010 - 25 employees



38 avenue des Frères Montgolfier



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.